Breast carcinoma genetics from a primary care perspective
โ Scribed by Wylie Burke; Nancy Press; Linda Pinsky
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 130 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
grate this information into routine clinical practice are needed. The small proportion of breast carcinoma cases due to inherited mutations must be taken into Linda Pinsky, M
๐ SIMILAR VOLUMES
## Background: The bcl-2 gene encodes for a protein that is involved in cell death regulation. it frequently is expressed in breast tumors, in which it is associated with favorable prognostic factors. it has been suggested that bcl-2 also may act as a modulator of response to chemotherapy and/or en
Two classes of inherited susceptibility genes may be considered in the etiology of breast and other common cancers. First, genes have been identified that confer a high degree of breast cancer (BC) risk, usually associated with hereditary syndromes, but disease-associated germline variants in these
Prostatic-specific antigen (PSA) is regarded as a specific marker secreted by normal and neoplastic acinar epithelial cells of the prostate gland; its detection by immunocytochemistry has been accepted as an indication of metastatic prostate cancer. This is ascribed to the commonly held belief that
Metastatic tumors in the breast from extramammary neoplasms are rare. In large studies, metastatic tumors involving the breast had a clinically observed rate of 0.4-2.0%. 1,2 The breast is most frequently involved by extramammary tumors of hematologic origin, followed by malignant melanoma and bronc